Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals
作者： Alberto Gabizon , Dorit Goren , Aviva T. Horowitz , Dinah Tzemach , Alexander Lossos
DOI: 10.1016/S0169-409X(96)00476-0
关键词:
摘要: … liposome drug delivery field has been the development of … -liposomal Dox is reached approximately 48 h after injection with a slow … High liposome localization in skin has been reported …
elsevier.com
sci-hub.se 参考文章(31)
Ronald G. Blasberg, Ronald G. Blasberg, Dennis R. Groothuis, Dennis R. Groothuis, Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Seminars in Oncology. ,vol. 13, pp. 70- 82 ,(1986) , 10.5555/URI:PII:0093775486900825
A. M. Dvorak, J. A. Nagy, H. F. Dvorak, J. T. Dvorak, Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. American Journal of Pathology. ,vol. 133, pp. 95- 109 ,(1988)
Y Namba, N Oku, Long-circulating liposomes. Critical Reviews in Therapeutic Drug Carrier Systems. ,vol. 11, pp. 231- 270 ,(1994)
Thomas R. Alosco, Richard B. Bankert, Eric Mayhew, Frank J. Martin, Scott S. Williams, Danilo D. Lasic, Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Research. ,vol. 53, pp. 3964- 3967 ,(1993)
Beatrice Uziely, Yechezkel Barenholz, Raphael Catane, Tamar Safra, Alberto Gabizon, Francis Martin, Rivka Cohen, Anthony Huang, Bela Kaufman, Prolonged Circulation Time and Enhanced Accumulation in Malignant Exudates of Doxorubicin Encapsulated in Polyethylene-glycol Coated Liposomes Cancer Research. ,vol. 54, pp. 987- 992 ,(1994)
Alberto A. Gabizon, Yechezkel Barenholz, Meir Bialer, Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharmaceutical Research. ,vol. 10, pp. 703- 708 ,(1993) , 10.1023/A:1018907715905
B Uziely, S Jeffers, R Isacson, K Kutsch, D Wei-Tsao, Z Yehoshua, E Libson, F M Muggia, A Gabizon, Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. Journal of Clinical Oncology. ,vol. 13, pp. 1777- 1785 ,(1995) , 10.1200/JCO.1995.13.7.1777
Daniel D Von Hoff, Maxwell W Layard, Peter Basa, HUGH L DAVIS Jr, Ann L Von Hoff, Marcel Rozencweig, Franco M Muggia, Risk Factors for Doxorubicin-lnduced Congestive Heart Failure Annals of Internal Medicine. ,vol. 91, pp. 710- 717 ,(1979) , 10.7326/0003-4819-91-5-710
Demetrios Papahadjopoulos, Eric Mayhew, Shi Kun Huang, Frank J. Martin, Syed Gilani, Danilo D. Lasic, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Research. ,vol. 52, pp. 6774- 6781 ,(1992)
P S Gill, B M Espina, F Muggia, S Cabriales, A Tulpule, J A Esplin, H A Liebman, E Forssen, M E Ross, A M Levine, Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Journal of Clinical Oncology. ,vol. 13, pp. 996- 1003 ,(1995) , 10.1200/JCO.1995.13.4.996